Postconditioning - Can the modified reperfusion improve the results of primary coronary angioplasty?;Postconditioning - Czy modyfikowana reperfuzja może poprawić wyniki pierwotnej angioplastyki wieńcowej?

Kardiologia Polska

Volumn 70, Issue 9, 2012, Pages 943-947

  Araszkiewicz, Aleksander ^a   Grygier, Marek ^a   Lesiak, Maciej ^a   Grajek, Stefan ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ISCHEMIC POSTCONDITIONING; REPERFUSION; REVIEW; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

EID: 84866677567     PISSN: 00229032     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Kelly CE, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet, 2003; 361: 13-20.
2. Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med, 2007; 13: 1121-1135.
3. Yetgin T, Manintveld OC, Duncker DJ, van der Giessen WJ. Postconditioning against ischemia reperfusion injury: ready for wide application in patients? Neth Heart J, 2010; 28: 389-392.
4. Verma S, Fedak PW, Weisel RD et al. Fundamentals of reperfusion injury for the clinical cardiologist. Circulation, 2002; 105: 2332-2336.
5. Matsamura K, Jeremy RW, Shaper J, Bechor LC. Progression of myocardial necrosis during reperfusion of ischemic myocardium. Circulation, 1998; 97: 795-804.
6. Gibbons RJ, Valeti VS, Avaoz PA et al. The quantification of infarct size. J Am Coll Cardiol, 2004; 44: 1533-1542.
7. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation, 1986; 74: 11124-1136.
8. Downey JM, Cohen MV. Why do we still not have cardioprotective drugs? Circ J, 2009; 73: 1171-1177.
9. Ross AM, Gibbons RJ, Stone GW et al. A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD- II). J Am Coll Cardiol, 2005; 45: 1775-1780.
10. Grygier M, Araszkiewicz A, Lesiak M et al. New method of intracoronary adenosine injection to prevent microvascular reperfusion injury in patients with acute myocardial infarction undergoing percutaneous coronary intervention. Am J Cardiol, 2011; 107: 1131-1113.
11. Piot C, Croisille P, Staat P et al. Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N Engl J Med, 2008; 359: 473-481.
12. Jennings RB, Schaper J, Hill ML et al. Effect of reperfusion late in the phase of reversible ischemic injury: changes in cell volume, electrolytes, metabolites, and ultrastructure. Circ Res, 1985; 56: 262-278.
13. Braunwald E. Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction and improved survival. Should the paradigm be expanded? Circulation, 1989; 79: 441-444.
14. Kaname M, Richmond WJ, Jutta S et al. Progression of myocardial necrosis during reperfusion of ischemic myocardium. Circulation, 1998; 97: 795-804.
15. Kloner RA, Ganote CE, Jennings RB. The no-reflow phenomenon after temporary coronary occlusion in the dog. J Clin Invest, 1974; 54: 1496-1508.
16. Jordan IE, Zhao ZQ, Vinten-Johansen J. The role of neutrophils in myocardial ischemia - reperfusion injury. Cardiovasc Res, 1999; 43: 860-878.
17. Hausenloy DJ, Ong SB, Yellon DM. The mitochondrial permeability transition pore as a target for preconditioning and postconditioning. Basic Res Cardiol, 2009; 104: 189-202.
18. Perelli M-G, Pagliaro P, Penna C. Ischemia/reperfusion injury and cardioprotective mechanisms. Role of mitochondria and reactive oxygen species. World J Cardiol, 2011; 3: 186-200.
19. Gustafsson AB, Gottlieb RA. Heart mitochondria:gates of life and death. Cardiovasc Res, 2008; 77: 334-343.
20. Follette DM, Fey K, Buckberg GD et al. Reducing postischemic damage by temporary modification of reperfusate calcium, potassium, pH, and osmolarity. J Thorac Cardiovasc Surg, 1981; 82: 221-238.
21. Kirklin JW. The science of cardiac surgery. Eur J Cardiothorac Surg, 1990; 4: 63-71.
22. Smolka G, Gołba KS, Malinowski M et al. Nowe oblicze modyfikowanej reperfuzji: postconditioning. Kardiol Pol, 2005; 63 (suppl. 2): 450-456.
23. Granfeldt A, Lefer DJ, Vinten-Johansen J. Protective ischaemia in patients: preconditioning and postconditioning. Cardiovasc Res, 2009; 83: 234-246.
24. Zhao ZQ, Corvera JS, Halkos ME et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol, 2003; 285: H579-H588.
25. Laskey WK. Brief repetitive balloon occlusions enhance reperfusion during percutaneous coronary intervention for acute myocardial infarction: a pilot study. Catheter Cardiovasc Interv, 2005; 65: 361-367.
26. Laskey WK, Yoon S, Calzada N, Ricciardi MJ. Concordant improvements in coronary flow reserve and ST-segment resolution during percutaneous coronary intervention for acute myocardial infarction: a benefit of postconditioning. Catheter Cardiovasc Interv, 2008; 72: 212-220.
27. Thibault H, Piot C, Staat P et al. Long-term benefit of postconditioning. Circulation, 2008; 117: 1037-1044.
28. Staat P, Rioufol G, Piot C et al. Postconditioning the human heart. Circulation, 2005; 112: 2143-2148.
29. Ma X, Zhang X, Li C, Luo MJ. Effect of postconditioning on coronary blood flow velocity and endothelial function and LV recovery after myocardial infarction. Interv Cardiol, 2006; 19: 367-375.
30. Yang XC, Liu Y, Wang LF et al. Reduction in myocardial infarct size by postconditioning in patients after percutaneous coronary intervention. J Invasive Cardiol, 2007; 19: 424-430.
31. Zhao WS, Xu L, Wang LF et al. A 60-s postconditioning protocol by percutaneous coronary intervention inhibits myocardial apoptosis in patients with acute myocardial infarction. Apoptosis, 2009; 14: 1204-1211.
32. Lønborg J, Kelbaek H, Vejlstrup N et al. Cardioprotective effects of ischemic postconditioning in patients treated with primary percutaneous coronary intervention, evaluated by magnetic resonance. Circ Cardiovasc Interv, 2010; 3: 34-41.
33. Sörensson P, Saleh N, Bouvier F et al. Effect of postconditioning on infarct size in patients with ST elevation myocardial infarction. Heart, 2010; 96: 1710-1715.
34. Freixa X, Bellera N, Ortiz-Perez JT. Ischemic postconditioning revisited: lack of effects on infarct size following primary percutaneous coronary intervention. Eur Heart J, 2012; 33: 103-112.
35. Vinten-Johansen J, Granfeldt A, Mykytenko J et al. The multidimensional physiological responses to postconditioning. Antioxid Redox Signal, 2011; 14: 791-810.
36. Ovize M, Baxter GF, Di Lisa F, et al. Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res, 2010; 87: 406-423.
37. Kin H, Zatta AJ, Lofye MT et al. Postconditioning reduces infarct size via adenosine receptor activation by endogenous adenosine. Cardiovasc Res, 2005; 67: 124-133.
38. Hausenloy DJ, Lecour S, Yellon DM. Reperfusion injury salvage kinase and survivor activating factor enhancement prosurvival signaling pathways in ischemic postconditioning: two sides of the same coin. Antioxid Redox Signal, 2011; 14: 893-907.
39. Lacerda L, Somers S, Opie LH, Lecour S. Ischaemic postconditioning protects against reperfusion injury via the SAFE pathway. Cardiovasc Res, 2009; 84: 201-208.
40. Heusch G. Reduction of infarct size by ischemic post-conditioning in humans: fact or fiction? Eur Heart J, 2011; doi:1093/eurheartj/ehr341.